In VivoReplication-Deficient Adenovirus Vector-Mediated Transduction of the Cytosine Deaminase Gene Sensitizes Glioma Cells to 5-Fluorocytosine
- 10 April 1996
- journal article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 7 (6) , 713-720
- https://doi.org/10.1089/hum.1996.7.6-713
Abstract
Viral vector-mediated transfer of chemosensitization genes represents a promising new approach to the treatment of cancer. Previous reports have demonstrated that transfection of the bacterial cytosine deaminase (cd) gene into mammalian cells can sensitize them to the otherwise nontoxic nucleoside, 5-fluorocytosine (5-FC). We now report that a replication-deficient adenovirus vector that transduces the cd gene (Ad.CMV-cd) highly sensitizes 9L gliosarcoma cells to 5-FC, and that gene transduction is associated with a potent bystander effect that is not dependent on direct cell-to-cell contact. Stereotactic injection of Ad.CMV-cd into established rat gliomas, followed by systemic administration of 5-FC in vivo, results in prolongation of survival.Keywords
This publication has 14 references indexed in Scilit:
- In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-FluorocytosineHuman Gene Therapy, 1995
- In VitroandIn VivoTransfer and Expression of Human Surfactant SP-A- and SP-B-Associated Protein cDNAs Mediated by Replication-Deficient, Recombinant Adenoviral VectorsHuman Gene Therapy, 1995
- Adenovirus‐mediated gene therapy of experimental gliomasJournal of Neuroscience Research, 1994
- Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection.Proceedings of the National Academy of Sciences, 1994
- Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. National Institutes of HealthHuman Gene Therapy, 1993
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- Characterization of the Escherichia coli codBA operon encoding cytosine permease and cytosine deaminaseMolecular Microbiology, 1992
- Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system.Proceedings of the National Academy of Sciences, 1992
- Immunology of central nervous system tumorsJournal of Neuroimmunology, 1989
- A new technique for the assay of infectivity of human adenovirus 5 DNAVirology, 1973